Morgan Stanley Novartis Ag Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Novartis Ag stock. As of the latest transaction made, Morgan Stanley holds 7,559,488 shares of NVS stock, worth $976 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

7,559,488

Previous 7,055,911 7.14%

Holding current value

$976 Million

Previous $787 Million 16.3%

% of portfolio

0.06%

Previous 0.06%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$101.96 - $121.01 $51.3 Million - $60.9 Million	503,577 Added 7.14%	7,559,488 $915 Million
Q1 2025 May 15, 2025	BUY	$97.14 - $115.57 $18.1 Million - $21.6 Million	186,756 Added 2.72%	7,055,911 $787 Million
Q4 2024 Feb 14, 2025	SELL	$96.78 - $117.18 $11.2 Million - $13.6 Million	-115,717 Reduced 1.66%	6,869,155 $668 Million
Q3 2024 May 14, 2025	SELL	$106.13 - $120.89 $45.8 Million - $52.2 Million	-431,807 Reduced 5.82%	6,984,872 $803 Million
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $45.8 Million - $52.2 Million	-431,807 Reduced 5.82%	6,984,872 $803 Million
Q2 2024 May 14, 2025	BUY	$92.57 - $107.37 $50.7 Million - $58.8 Million	547,524 Added 7.97%	7,416,679 $790 Million
Q2 2024 Oct 17, 2024	BUY	$92.57 - $107.37 $14.7 Million - $17 Million	158,298 Added 2.18%	7,416,679 $790 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $14.7 Million - $17 Million	158,298 Added 2.18%	7,416,679 $790 Million
Q1 2024 Oct 17, 2024	SELL	$95.27 - $108.47 $15.1 Million - $17.2 Million	-158,298 Reduced 2.13%	7,258,381 $702 Million
Q1 2024 Aug 16, 2024	BUY	$95.27 - $108.47 $15.8 Million - $18 Million	166,128 Added 2.34%	7,258,381 $702 Million
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $15.8 Million - $18 Million	166,128 Added 2.34%	7,258,381 $702 Million
Q4 2023 Aug 16, 2024	SELL	$92.27 - $101.54 $29.9 Million - $32.9 Million	-324,426 Reduced 4.37%	7,092,253 $716 Million
Q4 2023 Feb 13, 2024	BUY	$92.27 - $101.54 $10.6 Million - $11.6 Million	114,420 Added 1.64%	7,092,253 $716 Million
Q3 2023 Nov 15, 2023	SELL	$94.73 - $105.13 $27.2 Million - $30.2 Million	-287,598 Reduced 3.96%	6,977,833 $711 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $60.2 Million - $68.3 Million	650,965 Added 9.84%	7,265,431 $733 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $10.1 Million - $11.7 Million	126,270 Added 1.95%	6,614,466 $609 Million
Q4 2022 Feb 14, 2023	BUY	$75.55 - $92.52 $28.5 Million - $34.9 Million	377,693 Added 6.18%	6,488,196 $589 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $21.5 Million - $25.2 Million	-288,283 Reduced 4.51%	6,110,503 $464 Million
Q2 2022 Oct 27, 2022	BUY	$80.52 - $93.75 $252 Million - $294 Million	3,134,810 Added 96.04%	6,398,786 $541 Million
Q2 2022 Aug 15, 2022	BUY	$80.52 - $93.75 $252 Million - $294 Million	3,134,810 Added 96.04%	6,398,786 $541 Million
Q1 2022 Oct 27, 2022	SELL	$80.11 - $90.62 $251 Million - $284 Million	-3,134,810 Reduced 48.99%	3,263,976 $286 Million
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $17.6 Million - $19.9 Million	-219,673 Reduced 6.31%	3,263,976 $286 Million
Q4 2021 Feb 14, 2022	BUY	$79.7 - $88.13 $21.3 Million - $23.6 Million	267,670 Added 8.32%	3,483,649 $305 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $263 Million - $306 Million	3,215,979 New	3,215,979 $263 Million

Others Institutions Holding NVS

# of Institutions

1,577

Shares Held

136M

Call Options Held

1.72M

Put Options Held

1.7M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $278B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account